Overview
Dr. Lekshmi Santhosh is a pulmonary medicine and critical care specialist who sees patients with a broad range of conditions related to the lungs. She is also the physician faculty lead of the specialized OPTIMAL Clinic for patients who have been hospitalized with COVID-19 or who have persistent pulmonary symptoms. In addition to working in the clinic, she cares for patients in the medical and neurological intensive care units, as well as those admitted to the hospital through the general inpatient medical service. Santhosh believes that medical care must begin with hearing a patient's story. Although she specializes in pulmonary medicine, she thinks carefully about the entire body. Her work in the ICU and the hospital's general medicine wards informs her consideration of interactions among all the organ systems. Santhosh's research focuses on medical education. She has particular interests in developing women in leadership roles, clinical reasoning (decision-making in health care), and subspecialty education and career choice. She also studies the process of transitioning patients out of intensive care. After earning a bachelor's degree in psychology/behavioral neuroscience at Yale University, Santhosh completed her medical degree at Harvard Medical School. She completed a residency in internal medicine at UCSF, serving as chief resident for an additional year. She also completed a fellowship in pulmonary and critical care medicine at UCSF and a master's degree in health professions education at the University of California, Berkeley. Santhosh is a member of the American Thoracic Society. She serves as associate program director for UCSF's fellowship program in pulmonary and critical care medicine. In her free time, Santhosh enjoys cooking and baking, dining out, traveling, hiking and spending time with her two daughters.
Dr. Santhosh is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), Lung Metastases, and Bronchiectasis.
Dr. Santhosh is board certified in American Board Of Internal Med/Critical Care Med, Critical Care Medicine, American Board Of Internal Medicine, Pulmonary Disease, and American Board Of Internal Medicine, Internal Medicine. She is actively involved in clinical research, co-authoring 97 peer reviewed articles. Dr. Santhosh is currently accepting new patients.
Graduate Institution
Residency
Specialties
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 Parnassus Ave., Sixth Floor, Room A6114, San Francisco, CA 94143
Additional Areas of Focus
Dr. Santhosh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Interstitial Lung Disease (ILD) Program
Dr. Paul J. Wolters specializes in the diagnosis and care of patients with interstitial lung disease, a category of disorders in which scarring of lung tissue affects breathing. Wolters is actively involved in research that aims to better understand the development of idiopathic pulmonary fibrosis, a type of interstitial lung disease. He is director of biological research for the UCSF Interstitial Lung Disease Program. Wolters received his medical degree from the University of Minnesota. He completed a residency in internal medicine at the University of Colorado, and a fellowship in pulmonary and critical care medicine at UCSF. He joined UCSF's division of pulmonary and critical care medicine in 1999. Dr. Wolters is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant. Dr. Wolters is board certified in American Board Of Internal Med/Critical Care Med, Critical Care Medicine and American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease. Dr. Wolters is currently accepting new patients.
University Of California San Francisco
Christopher Ryerson is a Pulmonary Medicine provider practicing medicine in San Francisco, California. Dr. Ryerson is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Lung Transplant, and Endoscopy.
Interstitial Lung Disease (ILD) Program
Dr. Laura Koth is a pulmonologist and an expert in interstitial lung disease. She is co-director of UCSF's interstitial lung disease center of excellence. Koth's research activities focus on the mechanisms of lung inflammation and macrophage activation. Macrophages are a type of white blood cell with important roles in immune response. Koth earned her medical degree from Harvard Medical School. She completed residency training in internal medicine at Massachusetts General Hospital, followed by a fellowship in pulmonary and critical care medicine UCSF. She joined the UCSF faculty in 2003. Dr. Koth is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Sarcoidosis, Hypersensitivity Pneumonitis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Koth is board certified in American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease. Dr. Koth is currently accepting new patients.
Frequently Asked Questions about Dr. Lekshmi Santhosh
How do I make an appointment with Dr. Lekshmi Santhosh?
You can book an appointment with Dr. Lekshmi Santhosh by calling their office at 415-353-2961. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Lekshmi Santhosh a top-rated expert for Long Haul COVID?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lekshmi Santhosh is classified as an Advanced expert for Long Haul COVID, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Lekshmi Santhosh specialize in?
While Dr. Lekshmi Santhosh is a Pulmonary Medicine, they have specific expertise in Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), and Lung Metastases. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.
Does Dr. Lekshmi Santhosh participate in research or clinical trials?
Yes. Dr. Lekshmi Santhosh has published 97 articles and abstracts on conditions like Long Haul COVID. You can view a list of Dr. Lekshmi Santhosh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Lekshmi Santhosh accept my insurance?
Dr. Lekshmi Santhosh accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 415-353-2961 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Long Haul COVIDDr. Santhosh isAdvanced. Learn about Long Haul COVID.
- Experienced
- Acute Interstitial PneumoniaDr. Santhosh isExperienced. Learn about Acute Interstitial Pneumonia.
- BronchiectasisDr. Santhosh isExperienced. Learn about Bronchiectasis.
- Chronic CoughDr. Santhosh isExperienced. Learn about Chronic Cough.
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19Dr. Santhosh isExperienced. Learn about COVID-19.
- Interstitial Lung DiseaseDr. Santhosh isExperienced. Learn about Interstitial Lung Disease.